3-(1,3-Benzothiazol-2-yl)-4-[4-(benzyloxy)phenyl]but-3-enoic acid

Catalog No.: 
ACSBMK855
CAS No.: 
749214-70-8
Molecular Formula: 
C24H19NO3S
Molecular Weight: 
401.49
3-(1,3-Benzothiazol-2-yl)-4-[4-(benzyloxy)phenyl]but-3-enoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$104.00InquiryInquiry
100mg95%$146.00InquiryInquiry
250mg95%$201.00InquiryInquiry
1g95%$496.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name3-(1,3-Benzothiazol-2-yl)-4-[4-(benzyloxy)phenyl]but-3-enoic acid
IUPAC Name(Z)-3-(benzo[d]thiazol-2-yl)-4-(4-(benzyloxy)phenyl)but-3-enoic acid
MDL No.MFCD03657731
Molecular FormulaC24H19NO3S
Molecular Weight401.49
SMILESO=C(O)C/C(=C/C1=CC=C(OCC2=CC=CC=C2)C=C1)C1=NC2=CC=CC=C2S1
InChI KeyKRFDRGKRBQQYEB-RGEXLXHISA-N
Synonym3-(1,3-benzothiazol-2-yl)-4-[4-(benzyloxy)phenyl]but-3-enoic acid;2-Benzothiazolepropanoic acid, β-[[4-(phenylmethoxy)phenyl]methylene]-
CAS No.749214-70-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACSBMK855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBMK855 route product structure diagram
    ACSBMK855749214-70-8
Inquiry

2. ACSBMK855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBMK855 route product structure diagram
    ACSBMK855749214-70-8
Inquiry

3. ACSBMK855 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSBMK855 route product structure diagram
    ACSBMK855749214-70-8
Inquiry

Comments (0)